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ABSTRACT 
Oral ingestion is most convenient and commonly employed route of drug delivery due to its ease of administration, least aseptic 
and flexibility in the design of dosage form. The objective of the study was to explore the necessity, advantages and various 
techniques of extended release matrix tablet to get a constant drug delivery rate and reproducible kinetics for advance delivery. 
Different types of extended release matrix tablet have been explained briefly along with the various formulation which mainly by 
wet granulation or direct compression method or by dispersion of solid particle within a porous matrix formed by using different 
polymers. Matrix controls the free rate of drug. Matrix tablets can be formulated by either direct compression or wet granulation 
method by using a variety of hydrophilic or hydrophobic polymers. The extended release matrix tablets can assure better patient 
compliance through reduction in total dose and dosage regimen, which can be great help to treat chronic diseases. This review 
highlights the types of matrices, mechanisms involved and evaluation studies. 
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INTRODUCTION 
Drugs are administered with a main aim of treatment of 
the diseases. Drugs are never administered in their pure 
form but are converted in a suitable dosage forms so 
that its onset and intensity of action as well as total 
duration of action can be checked
1
. An ideal controlled 
drug delivery system is that which delivers the drug at 
a specific rate locally or systemically for a specified 
period of time with minimum ﬂuctuation in plasma 
drug concentration, reduced toxicity and maximum 
efficiency. In present scenario conventional dosage 
forms of drugs are rapidly being replaced by the new 
and the novel drug delivery systems. Oral drug delivery 
is the most preferred and convenient route of drug 
administration due to high patient compliance, cost-
effectiveness, least sterility constraints, flexibility in 
the design of dosage form and ease of production
2
. 
Approximately 50% of the drug products available in 
the market are administered orally and historically, oral 
drug administration has been the predominant route for 
drug delivery as a result of more prominent strength, 
precision in dose, production ease, and formulation of 
tablets is favoured oral dosage form. Tablet 
accessibility in market ranges from generally straight 
forward immediate release formulation to complex 
sustained release or modified release dosage forms
3
. 
Sustained release drug delivery system was meant to 
discharge the medication in a delayed rate to keep up 
plasma drug levels. The medications having shorter 
half life are appropriate for the sustained release drug 
delivery system. Matrix tablets is a promising approach 
for the establishment of extended-release drug therapy 
as tablets offer the lowest cost approach to sustained 
and controlled release solid dosage forms. Matrix 
tablets can be defined as the oral solid dosage forms in 
which the drug is homogeneously dispersed or 
dissolved within the hydrophilic or hydrophobic 
polymeric matrices. Hypothetically, sustained release 
dosage form should release the drug by a zero-order 
mechanism which maintains drug plasma level time 
similar to intravenous infusion
4
. 
Matrix system is the release system which prolongs 
and controls the release of the drug, which is dissolved 
or dispersed. A matrix is defined as a well-mixed 
composite of one or more drugs with gelling agent i.e. 
hydrophilic polymers. Introduction of matrix tablet as 
sustained release has given a new breakthrough for 
novel drug delivery system in the field of 
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Pharmaceutical technology. Under gastric pH 
conditions, matrix tablet slowly erodes. Two 
mechanisms are operative, either of which is zero-order 
erosion and decreasing surface area, and dissolution of 
coated particles. The result in the ability to control 
active pharmaceutical ingredient‟s blood level‟s in a 
narrow range, above the minimum effective level and 
below toxic level
5
. 
 
Figure 1: Release of drug dispersed in an inert 
matrix system 
The drug molecule appears better supported sustained 
drug release profile in matrix frameworks by 
distinctive systems. Matrix tablets may be formulated 
by wet granulation or direct compression methods by 
dispersing solid particles within a porous matrix 
formed of hydrophilic and hydrophobic polymers
6-9
. 
Advantages of Sustained Release Matrix Tablets 
i) Patient compliance 
Lack of compliance is mainly seen with chronic 
disease which required long term treatment, as 
achievement of medication treatment relies upon the 
patient capacity to agree with the medication treatment. 
Patient compliance is affected by a many factors, like 
knowledge of ailment process, patient confidence in 
treatment, and understanding of patient related to a 
strict treatment plan. In addition to the difficulty of 
therapeutic regimens, the cost of therapy and local or 
systemic side effect of the dosage form. This issue can 
be set out to some degree by administering sustained 
release drug delivery system
10-14
. 
ii) Reduced 'see-saw' fluctuation 
Drug concentration in the systemic circulation and 
tissue compartments show „see saw‟ pattern frequently 
when the drug administration in conventional dosage 
form. The sizes of these variances fundamentally rely 
upon drug kinetics such as the rate of absorption, 
distribution, elimination and dosing intervals
15
. The 
'see-saw' pattern is more prominent just in case of 
drugs with biological half-life less than four hours, 
since recommended dosing intervals are rarely less 
than four hours. A well-designed sustained release drug 
delivery system can widely reduce the frequency of 
drug dosing and also maintain a steady drug 
concentration in blood circulation and target tissue 
cells
16
. 
iii) Total dose reduction 
To treat an ailing condition less measure of aggregate 
drug is used in Sustained release drug delivery systems. 
By reducing the total amount of drug, decrease in 
systemic or local side effects are observed. This would 
also lead to greater economy
17
. 
iv). Improvement of deficiency in treatment 
Ideal treatment of a disease requires an effective 
transfer of active drugs to the tissues, organs that need 
treatment. Very often doses far in excess to those 
required in the cells have to be administered in order to 
achieve the necessary therapeutically effective 
concentration. This unfortunately may lead to 
undesirable, toxicological and immunological effects in 
non-target tissue. A sustained release dosage form 
leads to better management of the acute or chronic 
disease condition
18
. 
v). Economy 
The initial unit cost of sustained release products is 
typically more than that of conventional dosage form 
because of the special nature of these compounds but 
importantly average cost of treatment over an prolong 
period of time may be less
19
.
  
Disadvantages of sustained release matrix tablets  
 Highly expensive. 
 Often poor systemic availability. 
 Need for additional patient education and 
counseling. 
 Dose dumping20. 
 Often poor in vivo-in vitro correlation21.  
Characteristics of Drug Suitable for sustained 
Release Tablet 
The ideal physicochemical and pharmacokinetic 
qualities of medications which can be defined as 
extended release tablet are as per the following:  
1. Atomic size ought to be beneath of 1000 Dalton.  
2. Aqueous solvency ought to be in excess of 0.1 
mg/ml for pH 1 to pH 7.8.  
3. The partition coefficient ought to be high5.  
4. Absorption mechanism ought to be diffusion and 
the general absorbability from all GI fragments 
discharge ought not to be impacted by pH and 
catalysts.  
5. Elimination half-life ought to be between 2 to 8 
hrs
7
.  
6. Drugs ought not to metabolize before absorption it 
cause less bioavailability.  
7. Absolute bioavailability ought to be at least 75% or 
more.  
8. Absorption rate constant (Ka) ought to be higher 
than discharge rate. Apparent volume of 
distribution (Vd) ought to be substantial.  
9. Total clearance ought not to rely upon dosage15.  
10. Elimination rate constant are required for design 
and therapeutic concentration (Css) ought to be low 
and smaller (Vd)
3,4,5
.
 
Polymers used in sustained release tablet 
The polymers most widely used in preparing matrix 
system include both hydrophilic and hydrophobic 
polymers. 
a) Hydrophilic Polymers 
Hydroxyl propyl methyl cellulose (HPMC), hydroxyl 
propyl cellulose(HPC), hydroxyl ethyl cellulose 
(HEC), Xanthan gum, Sodium alginate, poly(ethylene 
oxide), and cross linked homopolymers and co-
polymers of acrylic acid
22-24
. 
b) Hydrophobic Polymers 
This usually includes waxes and water insoluble 
polymers in their formulation
25
. 
c) Natural polymers  
Xanthan Gum, Guar Gum, Sodium Alginate, Pectin, 
Chitosan
25
. 
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d) Biodegradable polymers 
Polylactic acid (PLA), Polyglycolic acid (PGA), 
Polycaprolactone (PCL), Polyanhydrides, 
Polyorthoesters
26
. 
e) Non-biodegradable polymers 
Polyethylene vinyl acetate (PVA), 
Polydimethylsiloxane (PDS), Polyether urethane 
(PEU), Polyvinyl chloride (PVC), Cellulose acetate 
(CA), Ethyl cellulose (EC)
27
. 
 
METHODS OF PREPARATION 
1. Direct Compression 
In this method, finely powdered materials are 
compressed directly without changing the physical and 
chemical properties of the drug
28
. 
2. Wet Granulation 
In this method weighed quantities of drug and polymer 
are mixed with sufficient volume of 
the granulating agent. After enough cohesiveness was 
obtained, the mass is sieved and dried at 40°C and kept 
in a dessicator. Lubricants and Glidants are added and 
the tablets are compressed using a tablet compression 
machine
29
. 
3. Melt Granulation 
In melt granulation, meltable substance act as liquid 
binding agent and hence does not require the use of 
organic solvents. This substance can be added in the 
molten form over the substrate, which is then heated 
above its melting point. Various lipophilic binders such 
as Glyceryl Palmitostearate are used in melt 
granulation technique
16
. 
 
CLASSIFICATION OF MATRIX TABLETS 
A. On the Basis of Retardant Material Used 
1. Hydrophobic Matrices (Plastic matrices) 
In the hydrophobic matrix tablets, the active drug is 
dispersed in a tablet within a porous skeletal structure 
by direct compression of the drug with plastic 
materials. Sustained release is produced due to the fact 
that the dissolving drug has diffused through a network 
of channels that exist between compacted polymer 
particles
21
. Examples of materials that have been used 
as inert or hydrophobic matrices include polyethylene, 
polyvinyl chloride, ethyl cellulose and acrylate 
polymers and their copolymers. The rate controlling 
step in these formulations is liquid penetration into the 
matrix. The possible mechanism of release of drug in 
such type of tablets is diffusion. Such types of matrix 
tablets become inert in the presence of water and 
gastrointestinal fluid
30
. 
2. Lipid Matrices 
These matrices prepared by the lipid waxes and related 
materials. Drug release from such matrices occurs 
through both pore diffusion and erosion. Release 
characteristics are therefore more sensitive to digestive 
fluid composition than to totally insoluble polymer 
matrix. Carnauba wax in combination with stearyl 
alcohol or stearic acid has been utilized for retardant 
base for many sustained release formulation. 
3. Hydrophilic Matrices 
 Hydrophilic polymer matrix systems are widely used 
in oral controlled drug delivery because of their 
flexibility to obtain a desirable drug release profile, 
cost effectiveness, and broad regulatory acceptance. 
Hydrophilic matrix may be formulated by a wet 
granulation of the drug and hydrophilic matrix 
materials or by direct compression of the blended 
mixture of active ingredient and certain hydrophilic 
carriers
17
. 
The formulation of the drugs in gelatinous capsules or 
more frequently, in tablets, using hydrophilic polymers 
with high gelling capacities as base excipients is of 
particular interest in the field of controlled release. 
When immersed in fluid the drug release is controlled 
by a gel diffusion barrier that is formed and tablet 
erosion
31
.  
4. Fat- wax matrix tablet 
The strategies include in addition of drug into fat wax. 
The drug can be incorporated into fat wax granulations 
by spray congealing in air, blend congealing in an 
aqueous media with or without the aid of surfactant and 
spray-drying techniques. Granules are showered which 
get hard in air, mixing in a aqueous fluid media with or 
without the surfactant and dried by spray drying 
strategy. A suspension of drug and melted fat wax are 
solidify by utilizing fluidized-bed and steam jacketed 
blender or granulating with a solution of waxy 
material. In this type of matrix tablet, drug is 
discharged by straining and hydrolysis mechanism. 
5. Mineral Matrices  
Mineral matrices can be set up by utilizing polymers 
which are acquired from different types of sea weads. 
Examples includes Alginic acid which is a hydrophilic 
sugar. The polymers obtained from different species of 
seaweeds are used to prepare mineral matrices. Alginic 
acid, a hydrophilic carbohydrate obtained from brown 
seaweeds (Phaephyceae) by the use of dilute alkali
32
.  
B. On the basis of porosity of matrix 
1. Macro porous Systems 
In such systems the diffusion of drug occurs through 
pores of matrix, which are of size range 0.1 to 1 μm. 
This pore size is larger than diffusant molecule size
9
. 
2. Micro porous System 
Diffusion in this type of system occurs essentially 
through pores. For micro porous systems, pore size 
ranges between 50-200 A°, which is slightly larger than 
diffusant molecules size
8
. 
3. Non-porous System: Non-porous systems have no 
pores and the molecules diffuse through the network 
meshes. In this case, only the polymeric phase exists 
and no pore phase is present
6-9
. 
C. On the basis of the way of matrix preparations 
1. Floating matrix system 
In this type of matrix system, the bulk density of the 
matrix is lower than the gastric fluid in the stomach. 
After creating buoyancy in the stomach, the release of 
drug molecules from the 
matrix can occur slowly, which prolongs gastric 
residence time and thereby increases the 
bioavailability of fast release drug molecules
18
. 
2. pH sensitive matrix system 
In this type of matrix system, an enteric coating of the 
matrix system can provide protection for the drug from 
the harsh acidic media of the stomach. Thus, low pH 
sensitive drug molecules can reach the small intestine 
and colon safely. This matrix system works by 
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releasing the enteric coated drug at a specifically high 
pH value in the GIT, where drug absorption can occur 
in the right location. PH sensitive polymers such as 
HPMC- phthalate or cellulose acetate phthalate can be 
used in this type of matrix system
26
. 
3. Mucoadhesive matrix system 
Mucoadhesive matrix systems are designed to enable 
prolonged retention in the gastric region for several 
hours and hence significantly prolong the gastric 
residence time of drugs. Prolonged gastric retention 
improves bioavailability. In this type of matrix system, 
the release of the drug is controlled over a period of 
time
18
. The targeted tissues can be gastrointestinal, 
buccal, ocular, nasal, respiratory, rectal, urethral and 
vaginal tissues. In addition, this type of matrix system 
can be applied to any mucosal tissue in the body. The 
used materials in this system are swellable hydrophilic 
polymers which can interact with the glycoproteins 
being available in the mucous layer of the gut
27
. 
 
FACTORS AFFECTING DRUG RELEASE 
FROM MATRIX TABLETS 
A. Physicochemical factors  
Dose size 
In general, a single dose of 0.5-1.0g is considered 
maximal for a conventional dosage form. Drugs with a 
large dose size (> 500mg) are difficult to formulate into 
a matrix system because of the requirements of high 
amounts of the polymer as well as other matrix formers  
(excipients). Compounds that require large dosing size 
can sometimes be given in multiple amounts or 
formulated into liquid systems
33
.  
Drug solubility 
Polymer erosion is more predominates in the case of 
the matrix with insoluble drugs, while with soluble 
drugs a combination of diffusion and erosion determine 
the release of the drug. Diffusion of the drug depends 
upon the concentration gradient across the medium 
which is a function of solubility thus a drug with high 
solubility shows faster release while poorly water 
soluble drugs (< 0.01 mg/ml) often result in the 
incomplete release because of their poor 
solubility and dissolution rate in the matrix
12
. Drugs 
that exhibit pH-dependent solubility particularly in 
gastrointestinal pH range are poor candidate for matrix 
system
34
. 
Ionization, pka and aqueous solubility 
Most drugs are weak acids or bases. Since the 
unchanged form of a drug preferentially permeates 
across lipid membranes, it is important to note the 
relationship between the pka of the compound and the 
absorptive environment. Delivery systems that are 
dependent on diffusion or dissolution will likewise be 
dependent on the solubility of the drug in aqueous 
media. These dosage forms must function in an 
environment of changing pH, the stomach being acidic 
and the small intestine more neutral, the effect of 
Phone the release process must be defined
35
.  
Partition Coefficient 
When a drug is administered to the GI tract, it must 
cross a variety of biological membranes to produce a 
therapeutic effect in another area of the body
7
. 
Compounds which are lipophilic in nature having high 
partition coefficient are poorly aqueous soluble and it 
retain in the lipophilic tissue for the longer time. In 
case of compounds with very low partition coefficient, 
it is very difficult for them to penetrate the membrane, 
resulting in poor bioavailability. It is common to 
consider that these membranes are lipidic; therefore the 
partition coefficient of oil-soluble drugs becomes 
important in determining the effectiveness of 
membrane barrier penetration
36
.  
B. Biological factors 
Biological half-life 
Therapeutic compounds with short half-life are 
generally are excellent candidate for SR formulation, 
as this can reduce dosing frequency. The usual goal of 
an oral sustained release tablet is to maintain 
therapeutic blood levels over an extended period of 
time. To achieve this, drug must enter the circulation at 
approximately the same rate at which it is eliminated.  
In general, drugs with half-life shorter than 2 hr are 
poor candidates for sustained release preparation. 
Compounds with long half-lives, more than 8 hr are 
also generally not used in sustaining form, since their 
effect is already sustained
37
.  
Absorption 
Absorption of the drug should occur at a relatively 
uniform rate over the entire length of small intestine. If 
a drug is absorbed by active transport or transport is 
limited to a specific region of intestine, SR preparation 
may be disadvantageous to absorption. One method to 
provide sustaining mechanisms of delivery for 
compounds tries to maintain them within the stomach. 
This allows slow release of the drug, which then travels 
to the absorptive site. Since the purpose of forming a 
SR product is to place control on the delivery system, it 
is necessary that the rate of release is much slower than 
the rate of absorption
27
.  
 
EVALUATION PARAMETERS FOR EXTEND 
RELEASE MATRIX TABLET 
Thickness and Diameter  
Thickness and diameter of tablets are determined using 
Vernier Caliper.  
Hardness of the Tablet 
 Tablet hardness has been characterized as, “the force 
required breaking a tablet in a diametric compression 
test”. For every formulation, the hardness of three 
tablets is examined utilizing Monsanto hardness 
analyzer; end point is recognized by breaking the 
tablet
8-11
.
  
Friability  
Twenty tablets are weighed and placed in friabilator. 
The chamber is rotated for 4 minutes at a speed of 25 
rpm. the tablets are removed from the chamber and 
weighed again. Loss in weight indicates friability. The 
tablets to be considered of good quality if loss in 
weight is less than 0.8%
19
. 
Weight variation test 
This is an important process which comes under 
quality control test as per standard in one batch all 
tablet ought to be in uniform weight. Twenty tablets 
are weighed to determine the average weight and 
compared with single tablet weight. The percentage 
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weight variation is computed according to Indian 
Pharmacopoeial particular
26
.  
Determination of drug content 
The drug content of is determined by dissolving in a 
suitable solvent like pH 7.4 phosphate buffer solution 
and sample are analyzed with the visible 
spectrophotometer and standard calibration curve of 
the pure drug
19-23
.  
In-vitro Dissolution Testing 
In vitro dissolution testing is a vital instrument for 
assessment of the best formulation. The test is carried 
out to measure the amount of time required for certain 
percentage of drug to go into the solution under the 
specific test conditions. Rotating paddle type and 
rotating basket type apparatus can be used as per 
pharmacopoeial standards or as mentioned in 
monograph of particular drug Dissolution testing is 
likewise used to characterize the biopharmaceutical 
attributes and to distinguish conceivable hazard, for 
example, potential nourishment impacts on 
bioavailability or interaction with different drugs
18
.  
 
CONCLUSION 
The focus of this review article has been on the 
formulation of extended release matrix tablets, benefits 
and drawback, various types of polymers, technique of 
preparation and assessment parameters.  
As compared to conventional counterparts matrix 
tablets offer better patient compliance, maintains 
constant plasma drug concentration level, reduces 
chances of toxicity and once a day drug therapy 
reduces overall cost of treatment. Above discussion 
ends up on the conclusion that matrix tablets are 
helpful to overcome the patient incompliance and 
effectiveness of dosage form in evoking desired 
therapeutic response related problems linked with 
conventional dosage forms. So, this extend release 
formulation can be a suitable formulation which an 
antidiabetic drug which can be incorporated and better 
pharmacological action can be achieved. This article 
may be beneficial for many researcher interested to 
work on the matrix tablets. 
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Figure 2: Preparation of matrix tablets 
 
